The Mental Health Market Today
The need for mental health treatment
has skyrocketed in the last 12 months.
Treating conditions such as depression,
PTSD and axiety just to name
a few is becoming critical
in our communities.
A recent study has found that in patients with no previous psychiatric history, a diagnosis of COVID 19 was associated with increased incidence of a first psychiatric diagnosis in the following 14 to 90 days compared with
six other health events The Lancet
The lifetime prevalence in Canada and the United States of
PTSD is between 9%-10 %
Mental Health Spending in Canada: $4.7B annually within healthcare;
$6.3B on uninsured mental health services and time off for depression/anxiety.
However, treatments for many patients are not successful and/or
available medications have too many side effects.
Click above for Fast Facts about Mental Illness
The growth of the behavioral health treatment market globally
is expected to reach $240 billion by 2026
Of this, the current estimated psychedelic market value is approximately $100 billion
Over a dozen companies in this space have listed on various stock exchanges;
however, none have a similar focus on organic therapy mushrooms and
clinical and neuroscience expertise in comparison to PsiloTec.